10.3978/j.issn.2304-3881.2013.05.02
High-intensity focused ultrasound (HIFU) for the treatment of hepatocellular carcinoma: is it time to abandon standard ablative percutaneous treatments?
Hepatocellular Carcinoma (HCC) is the leading cause of death in patients with cirrhosis (1). Despite recent advances in early detection programs and the diffusion of surveillance protocols in patients with cirrhosis, only 30% to 40% of patients are diagnosed at an early stage and can benefit from radical therapies (1).
2
2019-07-18(万方平台首次上网日期,不代表论文的发表时间)
共4页
184-187